About Segmental progressive overgrowth syndrome with fibroadipose hyperplasia
Segmental progressive overgrowth syndrome with fibroadipose hyperplasia is a rare disease catalogued by Orphanet (ORPHA:314662). It is associated with the PIK3CA gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Segmental progressive overgrowth syndrome with fibroadipose hyperplasia trials.
Search ClinicalTrials.gov for "Segmental progressive overgrowth syndrome with fibroadipose hyperplasia" or filter by Orphanet code ORPHA:314662 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Segmental progressive overgrowth syndrome with fibroadipose hyperplasia trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Segmental progressive overgrowth syndrome with fibroadipose hyperplasia. Updated daily.